Last quarter (Q4 2021), iX Biopharma Ltd.'s total revenue was S$―, a decrease of -100.00% from the same quarter last year. In Q4, iX Biopharma Ltd.'s net income was S$―. See iX Biopharma Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 21	Jun 20	Jun 19	Jun 18	Jun 17
Total Revenue	S$ 294.00K	S$ 1.75M	S$ 985.00K	S$ 671.00K	S$ 246.00K	S$ 6.38M
Cost of Revenue	S$ 689.00K	S$ 2.13M	S$ 1.57M	S$ 1.20M	S$ 493.00K	S$ 4.14M
Gross Profit	S$ -395.00K	S$ -382.00K	S$ -587.00K	S$ -529.00K	S$ -247.00K	S$ 2.24M
Operating Expense	S$ 5.52M	S$ 9.70M	S$ 10.45M	S$ 11.39M	S$ 14.20M	S$ 10.81M
Operating Income	S$ -5.92M	S$ -10.08M	S$ -11.04M	S$ -11.91M	S$ -14.45M	S$ -8.57M
Net Non Operating Interest Income Expense	S$ -119.00K	S$ -167.00K	S$ -151.00K	S$ -38.00K	S$ -27.00K	S$ -106.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	S$ -5.76M	S$ -8.23M	S$ -10.50M	S$ -13.27M	S$ -15.23M	S$ -7.58M
Tax Provision	-	S$ 1.00K	S$ 0.00	S$ -22.00K	S$ 52.00K	S$ -191.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	S$ -5.76M	S$ -8.23M	S$ -10.50M	S$ -2.99M	S$ -15.09M	S$ -7.39M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	S$ 6.21M	S$ 11.82M	S$ 12.02M	S$ 12.59M	S$ 14.70M	S$ 14.95M
Net Income From Continuing And Discontinued Operation	S$ -5.76M	S$ -8.23M	S$ -10.50M	S$ -2.99M	S$ -15.09M	S$ -7.39M
Normalized Income	S$ -5.76M	S$ -8.23M	S$ -10.50M	S$ -13.25M	S$ -15.29M	S$ -7.39M
Interest Expense	S$ 119.00K	S$ 174.00K	S$ 238.00K	S$ 232.00K	S$ 250.00K	S$ 242.00K
EBIT	S$ -5.65M	S$ -8.06M	S$ -10.26M	S$ -13.04M	S$ -14.98M	S$ -7.34M
EBITDA	S$ -5.13M	S$ -7.00M	S$ -9.21M	S$ -11.82M	S$ -13.58M	S$ -6.06M

Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing